ATE369130T1 - Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen - Google Patents

Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen

Info

Publication number: ATE369130T1
Authority: AT; Austria
Prior art keywords: carbamat; prevention; compounds; treatment; motion disorders
Prior art date: 2001-02-27

Application number

AT02714978T

Other languages

English (en)

Inventor

Carlos R Plata-Salaman

Boyu Zhao

Roy E Twyman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2007-08-15

2002-02-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2007-08-15 Application granted granted Critical

2007-08-15 Publication of ATE369130T1 publication Critical patent/ATE369130T1/de

Links

KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical class NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 title 1
230000002265 prevention Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT02714978T 2001-02-27 2002-02-21 Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen ATE369130T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27168301P	2001-02-27	2001-02-27
US10/081,501 US6589985B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating movement disorders

Publications (1)

Publication Number	Publication Date
ATE369130T1 true ATE369130T1 (de)	2007-08-15

Family

ID=26765643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02714978T ATE369130T1 (de)	2001-02-27	2002-02-21	Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen

Country Status (27)

Country	Link
US (1)	US6589985B2 (de)
EP (1)	EP1411917B1 (de)
JP (1)	JP2004527492A (de)
KR (1)	KR100858232B1 (de)
CN (1)	CN1262272C (de)
AR (1)	AR033426A1 (de)
AT (1)	ATE369130T1 (de)
AU (1)	AU2002247204B2 (de)
BR (1)	BR0207831A (de)
CA (1)	CA2439478C (de)
CY (1)	CY1106924T1 (de)
CZ (1)	CZ20032299A3 (de)
DE (1)	DE60221670T2 (de)
DK (1)	DK1411917T3 (de)
ES (1)	ES2291454T3 (de)
HU (1)	HUP0303344A3 (de)
IL (2)	IL157592A0 (de)
MX (1)	MXPA03007719A (de)
MY (1)	MY157373A (de)
NO (1)	NO20033803L (de)
NZ (1)	NZ551954A (de)
PL (1)	PL364679A1 (de)
PT (1)	PT1411917E (de)
RS (1)	RS50676B (de)
RU (1)	RU2294739C2 (de)
TW (1)	TWI331524B (de)
WO (1)	WO2002067926A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7349301A (en) *	2000-07-21	2002-02-05	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
PL364680A1 (en) *	2001-02-27	2004-12-13	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en)	2001-07-16	2005-03-21	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ES2435403T3 (es)	2005-06-08	2013-12-19	Sk Biopharmaceuticals Co., Ltd.	Tratamiento de trastornos del sueño y vigilia
PE20070325A1 (es) *	2005-06-29	2007-05-12	Alza Corp	Formas de dosificacion oral que comprenden compuestos derivados de carbamato
AU2005335241B9 (en) *	2005-07-26	2012-12-20	Sk Biopharmaceuticals Co., Ltd.	Methods for treating substance-related disorders
MX2009004798A (es) *	2006-10-31	2009-08-12	Janssen Pharmaceutica Nv	Tratamiento de los trastornos generalizados del desarrollo.
MX350745B (es)	2009-11-06	2017-09-14	Sk Biopharmaceuticals Co Ltd *	El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
US8895609B2 (en)	2009-11-06	2014-11-25	Sk Biopharmaceuticals Co., Ltd.	Methods for treating attention-deficit/hyperactivity disorder
US9610274B2 (en)	2010-06-30	2017-04-04	Sk Biopharmaceuticals Co., Ltd.	Methods for treating bipolar disorder
US8623913B2 (en) *	2010-06-30	2014-01-07	Sk Biopharmaceuticals Co., Ltd.	Methods for treating restless legs syndrome
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9566261B2 (en)	2013-03-12	2017-02-14	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (de) *	2013-03-12	2024-09-11	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamatverbindungen zur verwendung in der vorbeugung oder behandlung pädiatrischer epilepsie
ES3059582T3 (en)	2016-02-29	2026-03-23	Bio Pharm Solutions Co Ltd	Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en)	2016-09-06	2019-02-05	Jazz Pharmaceuticals International Iii Limited	Formulations of (R)-2-amino-3-phenylpropyl carbamate
MX391363B (es) *	2016-12-14	2025-03-21	Sk Biopharmaceuticals Co Ltd	Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
AU2018278332B2 (en)	2017-06-02	2022-05-19	Jazz Pharmaceuticals Ireland Limited	Methods and compositions for treating excessive sleepiness
US10940133B1 (en)	2020-03-19	2021-03-09	Jazz Pharmaceuticals Ireland Limited	Methods of providing solriamfetol therapy to subjects with impaired renal function
JP2023539291A (ja) *	2020-08-31	2023-09-13	バイオ－ファームソリューションズカンパニーリミテッド	神経変性疾患の予防又は治療用フェニルアルキルカルバメート化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en)	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 CN CNB028089243A patent/CN1262272C/zh not_active Expired - Fee Related
- 2002-02-21 PT PT02714978T patent/PT1411917E/pt unknown
- 2002-02-21 HU HU0303344A patent/HUP0303344A3/hu unknown
- 2002-02-21 CA CA2439478A patent/CA2439478C/en not_active Expired - Fee Related
- 2002-02-21 DE DE60221670T patent/DE60221670T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02714978T patent/ES2291454T3/es not_active Expired - Lifetime
- 2002-02-21 NZ NZ551954A patent/NZ551954A/en unknown
- 2002-02-21 RS YUP-677/03A patent/RS50676B/sr unknown
- 2002-02-21 JP JP2002567293A patent/JP2004527492A/ja active Pending
- 2002-02-21 IL IL15759202A patent/IL157592A0/xx unknown
- 2002-02-21 US US10/081,501 patent/US6589985B2/en not_active Expired - Fee Related
- 2002-02-21 AT AT02714978T patent/ATE369130T1/de active
- 2002-02-21 DK DK02714978T patent/DK1411917T3/da active
- 2002-02-21 CZ CZ20032299A patent/CZ20032299A3/cs unknown
- 2002-02-21 WO PCT/US2002/005542 patent/WO2002067926A1/en not_active Ceased
- 2002-02-21 RU RU2003128985/14A patent/RU2294739C2/ru not_active IP Right Cessation
- 2002-02-21 MX MXPA03007719A patent/MXPA03007719A/es active IP Right Grant
- 2002-02-21 EP EP02714978A patent/EP1411917B1/de not_active Expired - Lifetime
- 2002-02-21 PL PL02364679A patent/PL364679A1/xx not_active Application Discontinuation
- 2002-02-21 AU AU2002247204A patent/AU2002247204B2/en not_active Ceased
- 2002-02-21 KR KR1020037011271A patent/KR100858232B1/ko not_active Expired - Fee Related
- 2002-02-21 BR BR0207831-7A patent/BR0207831A/pt not_active Application Discontinuation
- 2002-02-27 TW TW091103503A patent/TWI331524B/zh not_active IP Right Cessation
- 2002-02-27 MY MYPI20020692A patent/MY157373A/en unknown
- 2002-02-27 AR ARP020100698A patent/AR033426A1/es unknown
2003
- 2003-08-26 NO NO20033803A patent/NO20033803L/no not_active Application Discontinuation
- 2003-08-26 IL IL157592A patent/IL157592A/en not_active IP Right Cessation
2007
- 2007-10-10 CY CY20071101301T patent/CY1106924T1/el unknown

Also Published As

Publication number	Publication date
IL157592A (en)	2009-12-24
WO2002067926A1 (en)	2002-09-06
YU67703A (sh)	2006-08-17
AR033426A1 (es)	2003-12-17
HK1067305A1 (en)	2005-04-08
CN1262272C (zh)	2006-07-05
EP1411917B1 (de)	2007-08-08
KR100858232B1 (ko)	2008-09-12
NO20033803L (no)	2003-10-10
ES2291454T3 (es)	2008-03-01
BR0207831A (pt)	2004-06-22
RS50676B (sr)	2010-06-30
CY1106924T1 (el)	2012-09-26
PL364679A1 (en)	2004-12-13
IL157592A0 (en)	2004-03-28
KR20030074847A (ko)	2003-09-19
DK1411917T3 (da)	2007-09-24
US20020151585A1 (en)	2002-10-17
CA2439478C (en)	2010-05-18
NO20033803D0 (no)	2003-08-26
HUP0303344A3 (en)	2012-07-30
CN1505508A (zh)	2004-06-16
MXPA03007719A (es)	2004-11-12
PT1411917E (pt)	2007-09-17
HUP0303344A2 (hu)	2004-01-28
US6589985B2 (en)	2003-07-08
DE60221670T2 (de)	2008-04-30
EP1411917A1 (de)	2004-04-28
CZ20032299A3 (cs)	2004-08-18
CA2439478A1 (en)	2002-09-06
JP2004527492A (ja)	2004-09-09
DE60221670D1 (de)	2007-09-20
AU2002247204B2 (en)	2006-08-24
RU2294739C2 (ru)	2007-03-10
NZ551954A (en)	2008-07-31
TWI331524B (en)	2010-10-11
MY157373A (en)	2016-06-15
RU2003128985A (ru)	2005-03-10

Legal Events

Date

Code

Title

Description

2007-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1411917

Country of ref document: EP

Publication	Publication Date	Title
ATE369130T1 (de)	2007-08-15	Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60223694D1 (de)	2008-01-03	Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE602004010407D1 (de)	2008-01-10	Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60023128D1 (de)	2006-02-23	Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60317061D1 (de)	2007-12-06	Ibandronsäure zur behandlung und vorbeugung von osteoporose
EP1274444A4 (de)	2006-06-14	Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen
DE60232251D1 (de)	2009-06-18	Pharmazeutische zusammensetzungen zur behandlung von asthma
DE60224163D1 (de)	2008-01-31	Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE60208221D1 (de)	2006-01-26	Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
ATE286028T1 (de)	2005-01-15	Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60208186D1 (de)	2006-01-26	Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
DE69925865D1 (de)	2005-07-21	4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE60233186D1 (de)	2009-09-17	Verbessertes System zur Behandlung von Elementarschwefel-Rückständen
ATE361745T1 (de)	2007-06-15	Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE60214355D1 (de)	2006-10-12	Exemestan zur behandlung von hormonabhängigen störungen
DE60219687D1 (de)	2007-05-31	Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
ATE443060T1 (de)	2009-10-15	Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
ATE346597T1 (de)	2006-12-15	Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
DE60223707D1 (de)	2008-01-03	Calcium-l-threonat zur behandlung von knochenfrakturen
DE60036723D1 (de)	2007-11-22	Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
DE60117122D1 (de)	2006-04-20	Verwendung von mirtazapin zur behandlung von schlafstörungen